https://www.biospace.com/breckenridge-announces-final-approval-of-its-anda-for-asenapine-sublingual-tablets-2-5-and-10mg-strengths-generic-for-saphris
Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted final approval of its Abbreviated New Drug Application...
final approvalbreckenridgeannouncesandaasenapine